Korean medtech company EOFlow said last week that it won breakthrough status from the FDA for its closed-loop automated insulin delivery system for people with Type 1 diabetes.
The EOPancreas system features a wearable patch, continuous glucose monitoring systems and a closed-loop blood glucose control algorithm.
Get the full story at our sister site, Drug Delivery Business News.
The post EOFlow wins breakthrough status for wearable closed-loop insulin delivery tech appeared first on MassDevice.
from MassDevice https://ift.tt/2TNNNDd
Cap comentari:
Publica un comentari a l'entrada